These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21270522)

  • 21. Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents.
    Eilon GF; Gu J; Slater LM; Hara K; Jacobs JW
    Cancer Chemother Pharmacol; 2000; 45(3):183-91. PubMed ID: 10663635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H; Yu D; Agrawal S; Zhang R
    Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1.
    Huerta-Yepez S; Vega M; Escoto-Chavez SE; Murdock B; Sakai T; Baritaki S; Bonavida B
    Nitric Oxide; 2009 Feb; 20(1):39-52. PubMed ID: 18778787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.
    Fabbri F; Brigliadori G; Carloni S; Ulivi P; Tesei A; Silvestrini R; Amadori D; Zoli W
    Prostate; 2010 Feb; 70(2):219-27. PubMed ID: 19790230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-cancer efficacy of SREBP inhibitor, alone or in combination with docetaxel, in prostate cancer harboring p53 mutations.
    Li X; Wu JB; Chung LW; Huang WC
    Oncotarget; 2015 Dec; 6(38):41018-32. PubMed ID: 26512780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
    Altaf M; Monim-Ul-Mehboob M; Kawde AN; Corona G; Larcher R; Ogasawara M; Casagrande N; Celegato M; Borghese C; Siddik ZH; Aldinucci D; Isab AA
    Oncotarget; 2017 Jan; 8(1):490-505. PubMed ID: 27888799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB.
    Kim SM; Lee SY; Cho JS; Son SM; Choi SS; Yun YP; Yoo HS; Yoon DY; Oh KW; Han SB; Hong JT
    Eur J Pharmacol; 2010 Apr; 631(1-3):1-9. PubMed ID: 20056115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of saquinavir on imatinib-resistant chronic myelogenous leukemia cell lines.
    Timeus F; Crescenzio N; Ricotti E; Doria A; Bertin D; Saglio G; Tovo PA
    Haematologica; 2006 May; 91(5):711-2. PubMed ID: 16670078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.
    Stangelberger A; Schally AV; Rick FG; Varga JL; Baker B; Zarandi M; Halmos G
    Prostate; 2012 Apr; 72(5):555-65. PubMed ID: 21796649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Andrographolide sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Wei RJ; Zhang XS; He DL
    Asian J Androl; 2018; 20(2):200-204. PubMed ID: 28869219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2'-Hydroxy-4-methylsulfonylchalcone enhances TRAIL-induced apoptosis in prostate cancer cells.
    Ismail B; Fagnere C; Limami Y; Ghezali L; Pouget C; Fidanzi C; Ouk C; Gueye R; Beneytout JL; Duroux JL; Diab-Assaf M; Leger DY; Liagre B
    Anticancer Drugs; 2015 Jan; 26(1):74-84. PubMed ID: 25192452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1.
    Baritaki S; Huerta-Yepez S; Sakai T; Spandidos DA; Bonavida B
    Mol Cancer Ther; 2007 Apr; 6(4):1387-99. PubMed ID: 17431117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inorganic selenium sensitizes prostate cancer cells to TRAIL-induced apoptosis through superoxide/p53/Bax-mediated activation of mitochondrial pathway.
    Hu H; Jiang C; Schuster T; Li GX; Daniel PT; Lü J
    Mol Cancer Ther; 2006 Jul; 5(7):1873-82. PubMed ID: 16891474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
    Frankel A; Man S; Elliott P; Adams J; Kerbel RS
    Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
    Fan QL; Zou WY; Song LH; Wei W
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells.
    Li Y; Ahmed F; Ali S; Philip PA; Kucuk O; Sarkar FH
    Cancer Res; 2005 Aug; 65(15):6934-42. PubMed ID: 16061678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
    Petković F; Blaževski J; Momčilović M; Timotijević G; Zocca MB; Mijatović S; Maksimović-Ivanić D; Mangano K; Fagone P; Stošić-Grujičić S; Nicoletti F; Miljković D
    J Neuroimmunol; 2013 Jun; 259(1-2):55-65. PubMed ID: 23602714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect and mechanism of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma].
    Tian J; Hu X; Qu Q
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):324-8. PubMed ID: 25030585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.